Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease.

نویسندگان

  • Yoshiki Sawa
  • Yasushi Yoshikawa
  • Koichi Toda
  • Satsuki Fukushima
  • Kenji Yamazaki
  • Minoru Ono
  • Yasushi Sakata
  • Nobuhisa Hagiwara
  • Koichiro Kinugawa
  • Shigeru Miyagawa
چکیده

BACKGROUND Poor survival outcomes for patients with severe heart failure (HF) and the donor shortage for heart transplantation warrant the development of myocardial regenerative therapy. We performed a multicenter, phase II study to evaluate the safety and efficacy of autologous skeletal myoblast sheets (TCD-51073). METHODS AND RESULTS In 3 study sites, we enrolled 7 patients with severe chronic HF due to ischemic heart disease despite maximal therapy, all of whom underwent transplantation of TCD-51073. No serious arrhythmia was reported, and no changes were noted in the frequency of ventricular extrasystole frequency. The primary efficacy endpoint of the change in left ventricular ejection fraction (LVEF) on gated blood-pool scintigraphy at 26 weeks after transplantation showed that 5 subjects were responders (classified as "improved" or "unchanged"). In addition, LVEF on echocardiography improved over time, with a change in LVEF of 7.1±2.8% at 26 weeks posttransplantation. Among the 7 subjects, 6 showed improvement in New York Heart Association functional class by at least 1 class. The 6-min walk distance was 410.1±136.1 m before transplantation and 455.4±103.7 m at 26 weeks after transplantation. CONCLUSIONS This study demonstrated the feasibility and safety of the transplantation of TCD-51073 in the patients with severe chronic HF due to ischemic heart disease, suggesting that TCD-51073 might maintain or improve cardiac function, symptoms, and physical function.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Phase I Clinical Trial of Autologous Stem Cell–Sheet Transplantation Therapy for Treating Cardiomyopathy

BACKGROUND When transplanted into failing heart, autologous somatic tissue-derived cells yield functional recovery via paracrine effects that enhance native regeneration. However, the therapeutic effects are modest. We developed a method in which scaffold-free cell sheets are attached to the epicardial surface to maximize paracrine effects. This Phase I clinical trial tested whether transplanti...

متن کامل

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

BACKGROUND Successful autologous skeletal myoblast transplantation into infarcted myocardium in a variety of animal models has demonstrated improvement in cardiac function. We evaluated the safety and feasibility of transplanting autologous myoblasts into infarcted myocardium of patients undergoing concurrent coronary artery bypass grafting (CABG) or left ventricular assist device (LVAD) implan...

متن کامل

Endurance training induces fiber type-specific revascularization in hindlimb skeletal muscles of rats with chronic heart failure

Objective(s): Previous studies showed that skeletal muscle microcirculation was reduced in chronic heart failure. The aim of this study was to investigate the effects of endurance training on capillary and arteriolar density of fast and slow twitch muscles in rats with chronic heart failure. Materials and Methods: Four weeks after surgeries (left anterior descending (LAD) artery occlusion), chr...

متن کامل

Effectiveness of Electronic Health Care and Drug Monitoring Program to Prevent COVID-19 and Adherence to Therapeutic Regimen in Patients with Ischemic Heart Disease- A Pilot Study

Background and Aim: One of the high-risk groups due to the prevalence of COVID-19 are patients with chronic heart disease. The aim of this study was to evaluate the effectiveness of the electronic health care and drug monitoring program to prevent COVID-19 and adherence to therapeutic regimen of patients with chronic heart disease (ischemic heart disease). Methods: This pilot study is a quasi-e...

متن کامل

بررسی اثر درمانی ترکیب گلوکز، انسولین ، پتاسیم (GIK) و تأثیر آن بر روی سطوح خونی NT.Pro BNP و Hs.CRP در بیماران نارسایی حاد قلبی

Introduction & Objective: Cardiovascular diseases are the main cause of death in all countries in the recent century and congestive heart failure (CHF) is the reason of death in most pa-tients . The most common causes of CHF are ischemic heart disease, myopathies , valvular disease and hypertension. Mortality reduction is the aim in CHF treatment. Combination of glucose-insulin-potassium (GIK...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation journal : official journal of the Japanese Circulation Society

دوره 79 5  شماره 

صفحات  -

تاریخ انتشار 2015